DUBLIN--(BUSINESS WIRE)--The "dPCR and qPCR Market to 2025 - Global Analysis and Forecasts by Technology; Product; Application and Geography" report has been added to ResearchAndMarkets.com's offering.
The dPCR and qPCR market is expected to reach US$ 6,371.6 Mn in 2025 from US$ 3,255.5 in 2017. The market is estimated to grow with a CAGR of 9.1% from 2017-2025.
The dPCR and qPCR market is driven by the driving factor such as increasing incidence of genetic diseases, growth in investments & funds for dPCR and qPCR techniques and gene synthesis, increasing number of start-up companies and technological developments in PCR technologies are likely to drive the market in the coming years.
The market is likely to restrain its growth due to the factors such as technical limitations associated with qPCR and high cost of PCR systems. Whereas the increasing trend of developing droplet digital PCR for various applications are likely to propel the growth of the market.
Key Market Dynamics
Key Market Drivers
- Increasing Incidence Of Genetic Diseases
- Increase In Investments & Funds For Gene Synthesis
- Technological Advancements In PCR Technologies
Key Market Restraints
- High Costs Of PCR Systems
- Technical Limitations Associated With qPCR
Key Market Opportunities
- Growing Adoption Of PCR Methods In Emerging Countries
Future Trends
- Development Of Droplet Digital PCR (dDPCR).
Companies Mentioned
- Abbott
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- TaKARA BIO, INC
- Agilent Technologies, Inc.
- bioMrieux SA
- Danaher
- Fluidigm Corporation
For more information about this report visit https://www.researchandmarkets.com/research/pd4frz/dpcr_and_qpcr?w=4
